Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma
Abstract Postoperative adjuvant therapy has been indicated by advanced T classification for T3–4 oral squamous cell carcinoma (OSCC) and the significance of perineural invasion (PNI) and lymphovascular invasion (LVI) in treatment for T3–4 OSCC remains unclear. Ninety-eight cumulative patients with T...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-99280-2 |
id |
doaj-ed2318dfbc0e463cbe3274e132e64358 |
---|---|
record_format |
Article |
spelling |
doaj-ed2318dfbc0e463cbe3274e132e643582021-10-10T11:31:12ZengNature Publishing GroupScientific Reports2045-23222021-10-011111910.1038/s41598-021-99280-2Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinomaKuan-Chung Ting0Tsung-Lun Lee1Wing-Yin Li2Chia-Fan Chang3Pen-Yuan Chu4Yi-Fen Wang5Shyh-Kuan Tai6Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General HospitalDepartment of Otolaryngology-Head and Neck Surgery, Taipei Veterans General HospitalDepartment of Pathology, Taipei Veterans General HospitalDepartment of Otolaryngology-Head and Neck Surgery, Taipei Veterans General HospitalDepartment of Otolaryngology-Head and Neck Surgery, Taipei Veterans General HospitalDepartment of Otolaryngology-Head and Neck Surgery, Taipei Veterans General HospitalDepartment of Otolaryngology-Head and Neck Surgery, Taipei Veterans General HospitalAbstract Postoperative adjuvant therapy has been indicated by advanced T classification for T3–4 oral squamous cell carcinoma (OSCC) and the significance of perineural invasion (PNI) and lymphovascular invasion (LVI) in treatment for T3–4 OSCC remains unclear. Ninety-eight cumulative patients with T3–4 OSCC who underwent curative surgery between Jan 2002 and Dec 2010 were recruited and analyzed. Twenty-seven (27.6%) patients were PNI/LVI double positive. PNI/LVI double positive demonstrated independent predictive values for higher neck metastasis (LN+), higher distant metastasis (DM) and low 5-year disease-specific survival (DSS) rates (p < 0.001, p = 0.017, and p < 0.001, respectively) after controlling for other pathologic features of the primary tumors. A high DM rate of 33.3% was noted in PNI/LVI double-positive patients. Among the PNI/LVI double negative, single positive to double positive subgroups, increasing LN+, DM rates and decreasing DSS rate were observed. Among the 44 LN+ patients, PNI/LVI double positive remained associated with a markedly high DM rate of 42.9% and a poor 5-year DSS of 27.7%. PNI/LVI double positive plays important roles in prognostication and potential clinical application for T3–4 OSCC by independently predicting LN+, DM, and poor DSS, and can be used as a good marker to select DM high-risk patients for novel adjuvant therapy trials.https://doi.org/10.1038/s41598-021-99280-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kuan-Chung Ting Tsung-Lun Lee Wing-Yin Li Chia-Fan Chang Pen-Yuan Chu Yi-Fen Wang Shyh-Kuan Tai |
spellingShingle |
Kuan-Chung Ting Tsung-Lun Lee Wing-Yin Li Chia-Fan Chang Pen-Yuan Chu Yi-Fen Wang Shyh-Kuan Tai Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma Scientific Reports |
author_facet |
Kuan-Chung Ting Tsung-Lun Lee Wing-Yin Li Chia-Fan Chang Pen-Yuan Chu Yi-Fen Wang Shyh-Kuan Tai |
author_sort |
Kuan-Chung Ting |
title |
Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma |
title_short |
Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma |
title_full |
Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma |
title_fullStr |
Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma |
title_full_unstemmed |
Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3–4 oral squamous cell carcinoma |
title_sort |
perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in t3–4 oral squamous cell carcinoma |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2021-10-01 |
description |
Abstract Postoperative adjuvant therapy has been indicated by advanced T classification for T3–4 oral squamous cell carcinoma (OSCC) and the significance of perineural invasion (PNI) and lymphovascular invasion (LVI) in treatment for T3–4 OSCC remains unclear. Ninety-eight cumulative patients with T3–4 OSCC who underwent curative surgery between Jan 2002 and Dec 2010 were recruited and analyzed. Twenty-seven (27.6%) patients were PNI/LVI double positive. PNI/LVI double positive demonstrated independent predictive values for higher neck metastasis (LN+), higher distant metastasis (DM) and low 5-year disease-specific survival (DSS) rates (p < 0.001, p = 0.017, and p < 0.001, respectively) after controlling for other pathologic features of the primary tumors. A high DM rate of 33.3% was noted in PNI/LVI double-positive patients. Among the PNI/LVI double negative, single positive to double positive subgroups, increasing LN+, DM rates and decreasing DSS rate were observed. Among the 44 LN+ patients, PNI/LVI double positive remained associated with a markedly high DM rate of 42.9% and a poor 5-year DSS of 27.7%. PNI/LVI double positive plays important roles in prognostication and potential clinical application for T3–4 OSCC by independently predicting LN+, DM, and poor DSS, and can be used as a good marker to select DM high-risk patients for novel adjuvant therapy trials. |
url |
https://doi.org/10.1038/s41598-021-99280-2 |
work_keys_str_mv |
AT kuanchungting perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma AT tsunglunlee perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma AT wingyinli perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma AT chiafanchang perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma AT penyuanchu perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma AT yifenwang perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma AT shyhkuantai perineuralinvasionlymphovascularinvasiondoublepositivepredictsdistantmetastasisandpoorsurvivalint34oralsquamouscellcarcinoma |
_version_ |
1716829790688772096 |